Emulate

Human biology on a chip.

Emulate was founded in 2013, is headquartered in Boston, United States, lists 51–200 employees, and has $203.0M in recorded funding across 6 rounds.

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$203.0M
Last Round
$82.0M Series ESep 2021
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 7 investors for this company. The full record is or through the API.

About

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, spun out of Harvard's Wyss Institute in 2013. The company commercializes its Human Emulation System — microfluidic chips lined with living human cells that replicate organ-level biology — enabling pharmaceutical and biotech researchers to model disease and test drug candidates.

Summary

Emulate is a Biotech company based in Boston, United States, founded in 2013. It lists 51–200 employees. It has raised $203.0M in total across 6 rounds, most recently a $82.0M Series E round in Sep 2021. Investors include Northpond Ventures, Founders Fund and Alumni Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries ESep 2021
$82.0M

Sign up to see all 6 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Emulate on Indexed.vc
<a href="https://indexed.vc/companies/emulate"><img src="https://indexed.vc/api/badge/company/emulate" alt="Emulate on Indexed.vc" width="260" height="76" /></a>